SYNTHESIS
Papers
1312
135.6 (s, aryl-C), 135.7 (s, aryl-C), 136.9 [d, 2J(C,P) = 3.3 Hz, aryl-
C], 141.3 [d, 1J(C,P) = 43.8 Hz, C4], 142.1 [d, 2J(C,P) = 4.6 Hz, C5],
170.8 [d, 1J(C,P) = 47.1 Hz, C2].
[MesCPC4H4+ – CH3], 91 (16.7) [C6H4CH3 ], 77 (11.7) [C6H5 ], 56
(23.2) [C4H6 ], 55 (63.6) [C4H5 ].
+
+
+
+
C19H17O5PW calcd
(326.30) found
C
42.25
41.79
H
3.17
3.15
MS (EI, 70 eV): m/z (%) = 369 (40.3) [M+], 251 (43.0) [M+ – Mes +
H], 118 (100.0) [Mes+ – H], 91 (7.4) [C6H4CH3 ], 77 (29.4) [C6H5 ].
+
+
2,8-Dimesityl-1,7-diphosphatricyclo[3.2.1.02,7]oct-3-ene (18):
A solution of phosphaalkyne 1b (134 mg, 0.62 mmol) in toluene
(2 mL) was stirred at 55°C for 1 week. The solvent was then removed
at 25°C/10–3 mbar. Further purification of the orange, oily residue by
bulb-to-bulb distillation (50 – 250°C/10–3 mbar) or by column chro-
matography (silica gel, pentane/Et2O) was not possible due to unse-
lective decomposition.
4-Mesityl-2,5-diphenyl-1,3-thiaphosphole (14):
The reaction and workup of phosphaalkyne 1b (100 mg, 0.62 mmol)
in toluene (2 mL) and the mesoionic compound 13 (157 mg,
0.62 mmol) in toluene (1 mL) were analogous to the preceding proce-
dure and furnished 14 as a yellow oil; yield: 135 mg (59%).
IR (Et2O): ν = 2976, 2944, 2923, 2840, 1474, 1449, 1378, 850, 756,
691 cm–1.
1
31P NMR (C6D6): δ = –168.0 [d, J(P,P) = 158.3 Hz], –163.1 [d,
31P NMR (C6D6): δ = 217.5 (s).
1J(P,P) = 158.3 Hz].
1H NMR (C6D6): δ = 2.11 (s, 6H, o-CH3), 2.33 (s, 3H, p-CH3), 6.91
(s, 2H, aryl-H, Mes), 7.24–7.40 (m, 10H, aryl-H, Ph).
13C NMR (CDCl3): δ = 21.1 (s, p-CH3), 21.2 (s, o-CH3), 125.9 [d,
2J(C,P) = 13.3 Hz, aryl-C], 128.0 (s, aryl-C), 128.2 (s, aryl-C), 128.4
MS (EI, 70 eV): m/z (%) = 378 (42.9) [M+], 363 (13.0) [M+ – CH3],
216 (100.0) [M+ – MesCP], 162 (44.5) [MesCP+], 119 (13.8) [Mes+],
+
+
91 (16.7) [C6H4CH3 ], 77 (11.2) [C6H5 ].
2
[d, J(C,P) = 2.0 Hz, aryl-C], 128.5 (s, aryl-C), 129.0 (s, aryl-C),
Methyl 1,5,6-Tri-tert-butyl-3-mesityl-2-phosphabicyc-
lo[2.2.0]hexa-2,5-diene-4-carboxylate (20):
133.2 [d, 2J(C,P) = 19.2 Hz, aryl-C], 134.1 (s, aryl-C), 136.3 (s, aryl-
2
C), 136.4 [d, J(C,P) = 4.0 Hz, aryl-C], 136.5 (s, aryl-C), 136.9 (s,
To a magnetically stirred solution of cyclobutadiene 19 (172 mg,
0.62 mmol) in pentane (3 mL) at –78°C was added dropwise a solution
of phosphaalkyne 1b (100 mg, 0.62 mmol) in pentane (3 mL). The mix-
ture was then allowed to warm to 25°C over 4 h and stirred for 2 h at
r.t. The volatile components were removed at 25°C/10–3 mbar. Purifi-
cation of the remaining oil 20 was not possible by bulb-to-bulb distilla-
tion (50–250°C/10–3 mbar) due to thermal decomposition.
31P NMR (C6D6): δ = 335.9 (s).
aryl-C), 150.3 [d, 2J(C,P) = 10.0 Hz, C5], 157.5 [d, 1J(C,P) = 46.4 Hz,
C4], 177.4 [d, 1J(C,P) = 58.4 Hz, C2].
MS (EI, 70 eV): m/z (%) = 372 (33.3) [M+], 340 (6.9) [M+ – S], 147
(31.0) [MesCP+ – CH3], 119 (23.5) [Mes+], 91 (30.7) [C6H4CH3 ], 77
+
+
(39.9) [C6H5 ], 73 (100.0), 57 (69.7).
2-Mesityl-1-phosphacyclohexa-1,4-diene (15):
1H NMR (C6D6): δ = 1.23, 1.26, 1.41 (each s, each 9H, t-Bu), 2.15 (s,
3H, p-CH3), 2.42 (s, 6H, o-CH3), 3.20 (s, 3H, OCH3), 6.85 (s, 2H,
aryl-H).
At –78°C buta-1,3-diene (700 mg, 12.9 mmol) was condensed into a
pressure tube and a solution of phosphaalkyne 1b (100 mg,
0.62 mmol) in toluene (3 mL) added. The mixture was allowed to
warm to r.t. and then heated for 2 d at 55°C. After evaporation of the
solvent and excess buta-1,3-diene at 25°C/10–3 mbar a yellow/orange
oily residue was obtained which could not be purified by bulb-to-bulb
distillation (200°C/10–3 mbar), by column chromatography (silica
gel, pentane/Et2O), or by crystallization (toluene).
13C NMR (CDCl3): δ = 21.1 (s, p-CH3), 22.8 (s, o-CH3), 50.8 (s,
1
2
OCH3), 72.8 [d, J(C,P) = 19.3 Hz, C1], 78.5 [d, J(C,P) = 5.6 Hz,
C4], 136.3(s, m-C, Mes), 138.4 [d, 4J(C,P) = 5.6 Hz, o-C, Mes], 147.5
(s, p-C, Mes), 152.7 [d, J(C,P) = 20.1 Hz, C6], 158.8 [d, J(C,P) =
5.6 Hz, C5], 172.0 [d, J(C,P) = 4.8 Hz, CO], 224.0 [d, J(C,P) =
29.7 Hz, C3].
2
3
3
1
31P NMR (C6D6): δ = 215.7 (s).
MS (EI, 70 eV): m/z (%) = 216 (100.0) [M+], 201 (17.0) [M+ – CH3],
Due to impurities the remaining data could not be assigned.
MS (EI, 70 eV): m/z (%) = 440 (48.6) [M+], 425 (8.3) [M+ – CH3],
243 (78.7) [M+ – t-BuCCt-Bu, – CO2CH3], 207 (64.6) [M+ – MesCP
– CCO2CH3], 147 (19.3) [MesCP+ – CH3], 119 (8.1) [Mes+], 84
162 (61.1) [MesCP+], 147 (34.0) [MesCP+ – Me], 119 (56.3) [Mes+],
+
+
91 (27.2) [C6H4CH3 ], 77 (5.7) [C6H5 ].
1-η1-[2-Mesityl-1-phosphacyclohexa-1,4-diene]pentacarbonyl-
tungsten (17):
(100.0) [t-BuCHCH2 ], 57 (89.6) [t-Bu+].
+
Compound 15 (216 mg, 1.0 mmol) in THF (5 mL) was added to a
solution of W(CO)5•THF, prepared by irradiation of W(CO)6
(387 mg, 1.1 mmol) in THF (60 mL). After 5 h at r.t. the solvent was
removed at 25°C/10–3 mbar, the oily residue was eluted with pentane
(20 mL) and subjected to chromatography (silica gel, column: 1.8 ×
30 cm, pentane 200 mL) to furnish a pale yellow oil, which crystal-
lized from pentane at 2°C; yield: 340 mg (63%); mp 97°C.
IR (Et2O): ν = 3030–2860, 2076(CO), 1992 (CO), 1668, 1611, 1567,
1467, 1463, 1459, 1263, 1164, 1005, 849, 746, 667, 621 cm–1.
31P NMR (C6D6): δ = 170.0 [s, 1J(P,W) = 259.6 Hz].
4,5,6-Tri-tert-butyl-2-mesityl-1-aza-3-phosphabicyclo[2.2.0]-
hexadiene (22):
A solution of tri-tert-butylazete (21) (80 mg, 0.36 mmol) in pentane
(2 mL) was added dropwise to a solution of phosphaalkyne 1b
(59 mg, 0.36 mmol) at –78 ˚C in pentane (4 mL). Warming to r.t.
overnight was followed by removal of the solvent at 25°C/10–3 mbar.
The residue was extracted with pentane (5 mL) and then separated
from insoluble material by filtration through a D3 sinter filled with
Celite. Removal of the solvent at 25°C/10–3 mbar furnished 21 as a
colorless powder; yield: 127 mg (91%).
1H NMR (C6D6): δ = 2.10 (s, 6H, o-CH3), 2.11 (s, 3H, p-CH3), 2.40–
2.48, 2.63–2.75 (each m, 4H, 3,6-CH2), 5.17–5.26, 5.40–5.46 (each
m, 2H, H4,5), 6.77 (s, 2H, aryl-H).
31P NMR (C6D6): δ = 230.4 (s).
1H NMR (C6D6): δ = 0.98, 1.25, 1.28 (each s, each 9H, t-Bu), 2.06 (s,
3H, CH3), 2.42 [d, 5J(C,P) = 2.0 Hz, 3H, o-CH3], 2.70 (s, 3H, CH3),
6.74, 6.77 (each s, 2H, aryl-H).
13C NMR (CDCl3): δ = 19.6 (s, o-CH3), 21.0 (s, p-CH3), 31.4 [d,
2J(C,P) = 2.6 Hz, C3], 37.5 [d, 1J(C,P) = 9.3 Hz, C6], 120.3 [d,
3J(C,P) = 8.5 Hz, C4], 125.4 [d, 2J(C,P) = 11.9 Hz, C5], 129.2 (s, m-
C, Mes), 134.9 [d, 2J(C,P) = 12.7 Hz, i-C, Mes], 137.7 (s, p-C, Mes),
13C NMR (CDCl3): δ = 21.5 (s, p-CH3), 22.7 (s, o-CH3), 27.9 [d,
J(C,P) = 3.4 Hz, C(CH3)3], 30.0, 30.7 [each s, C(CH3)3], 31.3, 34.0
[each s, C(CH3)3], 36.7 [d, J(C,P) = 5.1 Hz, C(CH3)3], 89.7 [d, 1J(C,P)
4
1
137.9 [d, J(C,P) = 3.4 Hz, o-C, Mes], 181.4 [d, J(C,P) = 47.5 Hz,
C2], 194.5 [d, 2J(C,P) = 9.8 Hz, 1J(C,W) = 124.2 Hz, COeq], 198.8
[d, 2J(C,P) = 28.8 Hz, 1J(C,W) = 45.8 Hz, COax].
2
= 23.7 Hz, C4], 127.6 (s, m-C), 128.8 [d, J(C,P) = 12.7 Hz, i-C],
137.4 [d, 3J(C,P) = 5.1 Hz, o-C], 137.8 (s, p-C), 139.5 [d, 2J(C,P) =
3.4 Hz, C5], 162.1 [d, 3J(C,P) = 19.5 Hz, C6], 225.9 [d, 1J(C,P) = 37.3
Hz, C2].
MS (EI, 57 eV): m/z (%) = 540 (53.0) [M+], 484 (30.4) [M+ – 2 CO],
456 (35.2) [M+ – 3 CO], 428 (75.9) [M+ – 4 CO], 426 (85.6) [M+ – 3
CO – 2 CH3], 400 (49.1) [M+ – 5 CO], 398 (96.2) [M+ – 4 CO – 2
CH3], 396 (100), 393 (27.1) [M+ – CO – Mes], 199 (15.4)
MS (EI, 70 eV): m/z (%) = 383 (6.7) [M+], 178 (10.9) [M+ – MesCN],
147 (100.0) [MesCO+], 145 (5.0) [MesCN+], 119 (12.2) [Mes+].